Altre lingue Kaneka Corporation

Azioni

4118

JP3215800008

Tempo differito Japan Exchange Altri mercati azionari 03:30:11 17/07/2024			Variaz. 5gg	Var. 1 gen.
4.280 ^JPY	+0,07%		+1,71%	+19,46%

22/04	Sony Corporation adotta il prodotto stampato in schiuma di Kaneka Corporation a base di polimero biodegradabile Green Planet come materiale di imbottitura per i suoi televisori a grande schermo.	CI
08/02	Kaneka Corporation (TSE:4118) annuncia un programma di riacquisto di azioni per 2.000.000 azioni, pari al 3,08% per 8.000 milioni di yen.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kaneka : Data Sheet 2023	27/06
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	24/06
Kaneka Corporation's Equity Buyback announced on February 8, 2024 has closed with 2,000,000 shares, representing 3.09% for ¥7,811.77 million.	21/06
Kaneka : Integrated Report 2023	16/05
Schaumstoffformteil aus biologisch abbaubarem KANEKA-Polymer Green PlanetTM wird als Polstermaterial für Großbildfernseher von Sony verwendet	22/04
Foam Molded Product made from KANEKA Biodegradable Polymer Green PlanetTM Adopted for Sony’s Large-screen TV Cushioning Material	22/04
Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	22/04
Sony is the Industry's First to Eliminate Polystyrene Foam Packaging for Large TVs	18/04
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	01/04
Kaneka Corporation announces an Equity Buyback for 2,000,000 shares, representing 3.08% for ¥8,000 million.	08/02
Kaneka Corporation authorizes a Buyback Plan.	08/02
Kaneka erwirbt Japan Medical Device Technology	06/12
Kaneka Acquires Japan Medical Device Technology	06/12
Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd.	30/11
Kaneka : Acquires Japan Medical Device Technology	30/11
Kaneka : Quarterly Financial Results for the 2nd Quarter, Ended September 30, 2023	14/11
Kaneka : initiates Clinical Trial for Acute Spinal Cord Injury using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	30/08/23
Kaneka : Quarterly Financial Results for the 1st Quarter, Ended June 30, 2023	18/08/23
Kaneka : Quarterly Financial Summary for the 1st Quarter, Ended June 30, 2023	18/08/23
Kaneka : initiates Clinical Trial for Duchenne Muscular Dystrophy using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	28/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kaneka Corporation

Azioni

4118

JP3215800008

Altre lingue

Filtri